A launch expert with several decades of hands-on experience shaping launch strategies and bringing products to market in pharma, medical devices, and digital health.
Throughout my career, I led departments, teams, and projects at UCB Pharma, Abbott, Guidant, Baxter, McKinsey & Inc., and A.T. Kearney. I shaped and steered drug and device launches across various therapeutic areas, operating in both commercial and market access & pricing roles, globally and within EMEA/MEA regions. Every step of the way, I searched for pragmatic innovation, sustainable results, and mutual benefits for patients, healthcare systems, and the industry alike.
In 2020, leveraging two decades of corporate experience, I established Pretium Strategy, a boutique consulting firm specializing in new product planning and go-to-market strategies across the US, Europe, and other global markets. I partner with executive and operational teams of small to mid-size organizations, offering strategic and operational support on both a consulting and interim basis. My client base spans the pharmaceutical, biotechnology, and digital health sectors.
My core expertise includes:
I possess deep knowledge of major healthcare systems, regulatory landscapes, pricing and reimbursement demands, and market dynamics. My operational experience covers both pharmaceuticals and medical devices across fields such as immunology, cardiovascular health, chronic kidney disease, osteoporosis, urology, epilepsy, Parkinson's, rare skin and autoimmune diseases, and digital health solutions.
With a background marked by extensive industry experience, strategic acumen, strong stakeholder relationships, and a robust project management skill set, I am committed to propelling organizations forward with strategic insights and tailored solutions that ensure their growth and success.
Copyright © 2024 Pretium Strategy - All Rights Reserved.